NCT02042105View on ClinicalTrials.gov

A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

CompletedOBSERVATIONAL
Enrollment

3,649

Participants

Timeline

Start Date

November 11, 2013

Primary Completion Date

April 15, 2015

Study Completion Date

July 6, 2016

Conditions
Non-small-cell Lung Cancer
Trial Locations (2)

510080

Guangdong General Hospital, Guangzhou

Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

All Listed Sponsors
lead

Guangdong Association of Clinical Trials

OTHER

NCT02042105 - A Prospective Epidemiologic Study of ALK-Positive NSCLC in China | Biotech Hunter | Biotech Hunter